Fosun Pharmaceutical bought Concert Pharmaceuticals Concert Pharmaceuticals from 1/19/23

User image

Vladimir Petenev

News editor
press@blackterminal.com

Fosun Pharmaceutical bought Concert Pharmaceuticals for $576 million, or $8 per share.

Concert Pharmaceuticals

Review

Source:

{source} pictogram

ir.concertpharma.com

Vladimir Petenev

News editor

Write your comment first

News feed

Segezha Group reports for 3 months of 2025 by RAS

4/30/25 SGZH

YATEK reported for 2024 by IFRS

4/30/25 YAKG

Samolet reported for 3 months of 2025 by RAS

4/30/25 SMLT

MGKL reported for 2024 by RAS

4/30/25 MGKL

YATEK reported for 2024 by RAS

4/30/25 YAKG

TNS Energy Rostov-on-Don reported for 2024 by IFRS

4/30/25 RTSB

TNS Energy reports for 2024 by IFRS

4/30/25 TNSE

M.Video-Eldorado's GMV in 2024 to grow by 5%

4/30/25 MVID

Slavneft-Megionneftegaz reported for 2024 by IFRS

4/30/25 MFGS

Mostotrest reports for 2024 by IFRS

4/30/25 MSTT